|

Paclitaxel for Injection (Albumin Bound) Clinical Trials

6 actively recruiting trials

No change since May 2026

Pipeline

Phase 2: 1Phase 3: 2Phase 1/2: 3

Top Sponsors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2
The First Affiliated Hospital of Xiamen University1
Suzhou Suncadia Biopharmaceuticals Co., Ltd.1
Shanghai Yizhong Pharmaceutical Co., Ltd.1
Risen (Suzhou) Pharma Tech Co., Ltd.1

Indications

Cancer6
Recurrent Cervical Cancer1
Recurrent Breast Cancer1
Advanced Pancreatic Cancer1
Advanced Malignancies1

Other6 trials

A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors

Phase 1/2

A Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction Adenocarcinoma

Phase 2

A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer

Phase 3

A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer

Phase 1/2

Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C

Phase 1/2

Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.